NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Studies conducted at M. Tozaki et al on breast cancer recently published



September 25th, 2008

In this recently published article, scientists in Chiba, Japan conducted a study "To assess the efficacy of H-1 MR spectroscopy (MRS) to evaluate early responses to neoadjuvant chemotherapy in breast cancer patients, as compared to that of the standardized uptake value (SUV) in '$F-fluorodeoxyglucose (FDG) positron emission tomography (PET). This retrospective study included seven patients with breast cancer who had both single-voxel 'H MRS and PET/computed tomography (CIA acquired before, during, and after neoadjuvant chemotherapy."

"The averages of the Choline (Cho) integral value and peak SUV before chemotherapy were 2.5 (range, 1.25.3) and 7.5 (range, 1.9-19),...


Source: Women's Health Weekly (2008-09-25)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login